C57BL/6NCya-Lrrc42em1/Cya
Common Name
Lrrc42-KO
Product ID
S-KO-15098
Backgroud
C57BL/6NCya
Strain ID
KOCMP-77809-Lrrc42-B6N-VA
When using this mouse strain in a publication, please cite “Lrrc42-KO Mouse (Catalog S-KO-15098) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Lrrc42-KO
Strain ID
KOCMP-77809-Lrrc42-B6N-VA
Gene Name
Product ID
S-KO-15098
Gene Alias
A930011F22Rik
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 4
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000030360
NCBI RefSeq
NM_029985
Target Region
Exon 3~7
Size of Effective Region
~7.5 kb
Overview of Gene Research
Lrrc42, or Leucine-rich repeat containing 42, is a gene with significant implications in cancer development. It has been associated with multiple signaling pathways, such as the Wnt/β-catenin signaling pathway [3]. Its expression levels are related to cell proliferation, migration, invasion, and apoptosis, thus playing an important role in tumorigenesis [1,2,3].
Analysis of RNA-seq data from the TCGA database showed that Lrrc42 expression is upregulated in various tumor tissues like bladder, breast, and colorectal cancer, while downregulated in kidney chromophobe and thyroid carcinoma tissues [1]. In lung cancer, knockdown of Lrrc42 by siRNA suppressed cell growth, and its overexpression promoted growth. It may interact with and stabilize GATAD2B and MBD3 proteins, contributing to cell proliferation through p21Waf1/Cip1 regulation [2]. In colorectal cancer, silencing Lrrc42 suppressed cell proliferation, induced cell cycle arrest, and promoted apoptosis, and it was found to be regulated by ubiquitin specific peptidase 7 which stabilizes Lrrc42 by deubiquitination [3].
In conclusion, Lrrc42 is a key gene in cancer-related cellular processes. Functional studies through knockdown experiments in cell lines have revealed its role in promoting tumor cell proliferation, migration, and invasion in cancers like hepatocellular carcinoma, lung cancer, and colorectal cancer [1,2,3]. Understanding Lrrc42 may provide new therapeutic targets for inhibiting cancer progression.
References:
1. Huang, Rongfu, Yao, Jianfeng, Liu, Lei, Li, Hua, Huang, Baoshan. 2025. Comprehensive analysis of LRRC42 as a potential biomarker and key cellular processes in cancer development. In Scientific reports, 15, 5169. doi:10.1038/s41598-025-88467-6. https://pubmed.ncbi.nlm.nih.gov/39939664/
2. Fujitomo, Takashi, Daigo, Yataro, Matsuda, Koichi, Ueda, Koji, Nakamura, Yusuke. 2014. Identification of a nuclear protein, LRRC42, involved in lung carcinogenesis. In International journal of oncology, 45, 147-56. doi:10.3892/ijo.2014.2418. https://pubmed.ncbi.nlm.nih.gov/24806090/
3. Li, Yunze, Sun, Xin, Huang, Zhe. 2024. USP7 facilitates deubiquitination of LRRC42 in colorectal cancer to accelerate tumorigenesis and augment Wnt/β-catenin signaling. In Biochimica et biophysica acta. Molecular cell research, 1872, 119859. doi:10.1016/j.bbamcr.2024.119859. https://pubmed.ncbi.nlm.nih.gov/39393471/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.